Role of endothelin-1 in astrocyte responses after acute brain damage

被引:0
作者
Hama, H
Kasuya, Y
Sakurai, T
Yamada, G
Suzuki, N
Masaki, T
Goto, K
机构
[1] UNIV TSUKUBA, INST BASIC MED SCI, DEPT PHARMACOL, TSUKUBA, IBARAKI 305, JAPAN
[2] TAKEDA CHEM IND LTD, RES INST, TSUKUBA, IBARAKI, JAPAN
[3] KYOTO UNIV, FAC MED, DEPT PHARMACOL, SAKYO KU, KYOTO, JAPAN
关键词
endothelin-1; cold-injury; astrocyte; anti-ET antibody; proliferation;
D O I
10.1002/(SICI)1097-4547(19970315)47:6<590::AID-JNR4>3.0.CO;2-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We examined the possibility of the involvement of endothelin (ET)-1, a potent vasoactive peptide, in the process of astrocyte proliferation after brain injury, Acute brain damage in rats was induced by cold-injury, Astrocytes changed from a differentiated state to an immature, RC-1-positive state immediately after the injury, In the injured site, the level of ET-1-like immunoreactivity in the tissue was significantly increased on the first postoperative day and was sustained at a high level for 5 days, ET(B) receptor mRNA was markedly but transiently down-regulated only on the first day after the injury, Brain extracts (BE) were prepared from the injured tissues, and their effects on the proliferative characteristics of astrocytes were examined in primary culture of astrocytes. The flat morphology, which was observed in association with cell proliferation, and DNA synthesis of astrocytes were enhanced by treatment with each of the BE from 1 (D1-BE), 3 and 5 days after the injury, A monoclonal antibody that recognizes the C-terminus of rat ET-1 and ET-3 inhibited the DNA synthesis of astrocytes induced by D1-BE, These results provide experimental evidence that ET-1 may participate in the initiation of gliosis in the acute phase of brain damage. (C) 1997 Wiley-Liss, Inc.
引用
收藏
页码:590 / 602
页数:13
相关论文
共 50 条
[41]   ROLE OF ENDOTHELIN-1 IN LEFT VENTRICULAR REMODELING PROCESS [J].
Sisakyan, H. S. ;
Sahakyan, L. G. .
NEW ARMENIAN MEDICAL JOURNAL, 2015, 9 (04) :102-105
[42]   Role of endothelin-1 in the skin fibrosis of systemic sclerosis [J].
J. Jing ;
T. T. Dou ;
J. Q. Yang ;
X. B. Chen ;
H. L. Cao ;
M. Min ;
S. Q. Cai ;
M. Zheng ;
X. Y. Man .
European Cytokine Network, 2015, 26 :10-14
[43]   Decompensation characterized by decreased perfusion of the heart and brain during hemorrhagic shock: Role of endothelin-1 [J].
Sharma, AC ;
Singh, G ;
Gulati, A .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2002, 53 (03) :531-536
[44]   Role of endothelin-1 for the regulation of renal pelvic function [J].
Steinbach, Antje ;
Schaper, Katrin ;
Koenen, Anna ;
Schlueter, Torsten ;
Zimmermann, Uwe ;
Rettig, Rainer ;
Grisk, Olaf .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2016, 468 (08) :1467-1478
[45]   RELEASE MECHANISM OF ENDOTHELIN-1 AND BIG ENDOTHELIN-1 AFTER STIMULATION WITH THROMBIN IN CULTURED PORCINE ENDOTHELIAL-CELLS [J].
KOHNO, M ;
YOKOKAWA, K ;
HORIO, T ;
YASUNARI, K ;
MURAKAWA, K ;
IKEDA, M ;
TAKEDA, T .
JOURNAL OF VASCULAR RESEARCH, 1992, 29 (02) :56-63
[46]   Effect of bosentan on leptin and endothelin-1 concentration in plasma and brain after cardiac arrest in rats [J].
Ostrowski, RP ;
Kowalska, Z ;
Jauszewski, S ;
Kapuscinski, A .
DRUG DEVELOPMENT RESEARCH, 2005, 64 (03) :137-144
[47]   POSSIBLE SOURCES OF ENDOTHELIN-1 IN DAMAGED RAT-BRAIN [J].
YAMADA, G ;
HAMA, H ;
KASUYA, Y ;
MASAKI, T ;
GOTO, K .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 26 :S486-S490
[48]   Endogenous endothelin-1 initiates astrocytic growth after spinal cord injury [J].
Uesugi, M ;
Kasuya, Y ;
Hama, H ;
Yamamoto, M ;
Hayashi, K ;
Masaki, T ;
Goto, K .
BRAIN RESEARCH, 1996, 728 (02) :255-259
[49]   PROTECTIVE EFFECTS OF ENDOTHELIN-1 ON ACUTE-PANCREATITIS IN RATS [J].
KOGIRE, M ;
INOUE, K ;
HIGASHIDE, SI ;
TAKAORI, K ;
ECHIGO, Y ;
GU, YJ ;
SUMI, S ;
UCHIDA, K ;
IMAMURA, M .
DIGESTIVE DISEASES AND SCIENCES, 1995, 40 (06) :1207-1212
[50]   Rationale and perspective of endothelin-1 antagonism in acute heart failure [J].
Kiowski, W ;
Suetsch, G ;
Oechslin, E ;
Schalcher, C ;
Brunner-LaRocca, HP ;
Bertel, O .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2001, 38 :S53-S57